Hvilken er prisen på Organicell Regenerative Medicine, Inc. (OCEL)

Prisen på Organicell Regenerative Medicine, Inc. (OCEL) er $1.77

Hva er markedsverdien på Organicell Regenerative Medicine, Inc. (OCEL)

Markedsverdien på Organicell Regenerative Medicine, Inc. (OCEL) er $12.89M

Organicell Regenerative Medicine, Inc. (OCEL) Prishistorikk

Organicell Regenerative Medicine, Inc. is a clinical-stage biopharmaceutical firm dedicated to pioneering biological therapies for degenerative conditions. Their primary investigational product is Zofin, an acellular biological treatment sourced from perinatal material. This therapeutic is specifically processed to preserve its inherent microRNAs, without the inclusion of any artificial additives or diluents. Zofin is currently undergoing Phase I/II clinical evaluation for its efficacy against COVID-19. Beyond its core drug development, Organicell also offers independent educational, promotional, and marketing solutions to various healthcare sectors, including medical, anti-aging, and regenerative service providers. The company maintains key research collaborations: one with the Centers for Disease Control and Prevention (CDC) to explore Zofin's anti-inflammatory and anti-infective capabilities in experimental influenza models, and another with Oklahoma State University to assess Zofin's potential in treating severe respiratory illnesses stemming from viruses with pandemic risk. Founded in 2011, this Miami, Florida-based company initially operated as Biotech Products Services and Research, Inc. It adopted its current name, Organicell Regenerative Medicine, Inc., in June 2018.

År	Ytelse
2024	42.05%
2023	-70.50%
2022	-42.43%
2021	-72.54%
2020	504.63%
2019	263.71%
2018	-40.90%
2017	-91.64%
2016	0.00%

År

Ytelse

2024

42.05%

2023

-70.50%

2022

-42.43%

2021

-72.54%

2020

504.63%

2019

263.71%

2018

-40.90%

2017

-91.64%

2016

0.00%

Selskap	Aksjepris	Endring 1år%	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$515.58	32.24%	US
Argenx SE ARGX.US	$992.01	50.00%	NL
CSL Limited CSL.AX	$111.31	-36.83%	AU
Lonza Group AG LONN.SW	$734.30	6.65%	CH
Samsung Biologics Co.,Ltd. 207940.KS	$1.06K	-7.04%	KR

Selskap

Aksjepris

Endring 1år%

Land